Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Debt question
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by 1healthon Feb 13, 2016 11:07pm
82 Views
Post# 24556960

RE:Debt question

RE:Debt question
jimmy you are short on every stock, Copy of youy posting-

by jimmyjeblonski

   
V.SYZ

Why no tsx listing?

0 stars
 
 

This company is ignored by the street and should be valued higher. Any word...

16 minutes ago
T.CXR

Debt question

5 stars
 
 

Has CXR related a plan for the debt repayment yet? How quickly would they be...

23 minutes ago
T.DIV

RE:Bigger Picture

3.5 stars
 
 

A dividend of 10% does not mean that the market thinks the dividend will be...

4 days ago
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities